Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 9, Issue 4, 1997, Pages 591-593

  Auchus, Alexander P ^a,b   Bissey Black, Cheryl ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; HALOPERIDOL; PLACEBO;

AGED; AGITATION; ALZHEIMER DISEASE; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; CONTROLLED CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; MOTOR DYSFUNCTION; NERVOUSNESS; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREMOR;

EID: 0031474315     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.9.4.591     Document Type: Article

References (15)

1. Report of the Secretary's Task Force on Alzheimer's Disease, in Alzheimer's Disease. Washington, DC, US Department of Health and Human Services, 1980
2. Argyle N, Jestice S, Brook CPB: Psychogeriatric patients: their supporters' problems. Age Aging 1985; 14:355-360
3. Schneider LS, Pollock VE, Lyness SA: A metaanalysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc 1990; 38:553-563
4. Cross AJ, Crow TJ, Ferrier IN, et al: Serotonin receptor changes in dementia of the Alzheimer type. J Neurochem 1984; 43:1574-1581
5. Volicer L, Langlais PJ, Matson WR, et al: Serotonin system in dementia of the Alzheimer type: abnormal forms of 5-hydroxytryptophan and serotonin in cerebrospinal fluid. Arch Neurol 1985; 42:1158-1161
6. Schneider LS, Severson JA, Chui HC, et al: Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions. Psychiatry Res 1988; 25:311-322
7. Whitehouse PJ: Neurotransmitter receptor alterations in Alzheimer's disease: a review. Alzheimer Dis Assoc Disord 1987; 1:9-18
8. Nyth AL, Gottfries CG: The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry 1990; 157:894-901
9. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944
10. Cohen-Mansfield J: Agitated behaviors in the elderly, II: preliminary results in the cognitively deteriorated. J Am Geriatr Soc 1986; 34:722-727
11. Reisberg B, Borenstein J, Salob SP, et al: Behavioral symptoms in Alzheimer's disease: phenomenology and treatment. J Clin Psychiatry 1987; 48(suppl 5):9-15
12. Meinert CL: Clinical Trials: Design, Conduct, and Analysis. New York, Oxford University Press, 1986
13. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
14. Stotsky B: Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders. Clin Ther 1984; 6:546-559
15. Tinetti ME, Speechley M, Ginter SF: Risk factors for falls among elderly persons living in the community. N Engl J Med 1988; 319:1701-1707